Torrent Pharma

₹2604.6 3.2 | 0.1%

WEBSITE BSE:500420 NSE : TORRENT PHAR 13 May, 15:57

Market Cap ₹88151 Cr.

Stock P/E 59.0

P/B 12.3

Current Price ₹2604.6

Book Value ₹ 211.3

Face Value 5

52W High ₹2782

Dividend Yield 0.84%

52W Low ₹ 1598.5

Edit Ratio

Torrent Pharma Research see more...

Overview Inc. Year: 1972Industry: Pharmaceuticals & Drugs

Torrent Pharmaceuticals Ltd is an India-based pharmaceutical business enterprise. The Company is engaged in studies, improvement, manufacturing and advertising of generic pharmaceutical formulations. It operates in the gastrointestinal (GI), central nervous system (CNS),therapeutic segments of cardiovascular (CV), and vitamins minerals nutritionals (VMN). It additionally has presence in therapeutic areas, consisting of anti-epileptic, anti-diabetic, anti-most cancers, anti-zits, corticosteroids and cosmeceuticals. It has developed complex formulations for global markets based totally on oral solids, injections, inhalation technologies, long-appearing depot injections ophthalmic, nasal, semisolids for outside packages and multi-particulate extended-launch oral structures. The Company is growing numerous in-house new chemical entities (NCE) inside the regions of metabolic, cardiovascular, gastrointestinal, dermatological and breathing problems. It has a presence across more than forty countries.

Torrent Pharma Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Torrent Pharma Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	2137	2108	2131	2347	2291	2491	2491	2591	2660	2732
Other Income	51	48	56	30	16	-10	9	34	26	-33
Total Income	2188	2156	2187	2377	2307	2481	2500	2625	2686	2699
Total Expenditure	1477	1570	1570	1635	1612	1767	1764	1800	1835	1863
Operating Profit	711	586	617	742	695	714	736	825	851	836
Interest	71	62	57	55	69	102	107	103	91	80
Depreciation	168	167	162	155	163	193	196	191	201	213
Exceptional Income / Expenses	0	0	-485	0	0	0	0	0	0	88
Profit Before Tax	472	357	-87	532	463	419	433	531	559	631
Provision for Tax	156	108	31	178	151	127	146	153	173	188
Profit After Tax	316	249	-118	354	312	292	287	378	386	443
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	316	249	-118	354	312	292	287	378	386	443
Adjusted Earnings Per Share	9.3	7.4	-3.5	10.5	9.2	8.6	8.5	11.2	11.4	13.1

Torrent Pharma Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	3211	4185	4653	6667	5816	5950	7673	7939	8005	8508	9620	10474
Other Income	43	38	286	229	223	307	64	121	57	197	63	36
Total Income	3255	4223	4939	6896	6039	6257	7736	8061	8061	8705	9683	10510
Total Expenditure	2519	3233	3633	3937	4438	4609	5696	5769	5524	6077	6796	7262
Operating Profit	736	990	1306	2959	1601	1648	2040	2292	2537	2628	2887	3248
Interest	34	59	175	184	206	308	504	451	353	255	333	381
Depreciation	83	87	191	238	307	409	618	654	658	662	707	801
Exceptional Income / Expenses	-37	0	0	-194	0	0	-357	0	0	-485	0	88
Profit Before Tax	582	844	940	2343	1088	931	562	1187	1526	1226	1847	2154
Provision for Tax	147	180	189	610	155	253	125	162	274	449	602	660
Profit After Tax	435	664	751	1733	934	678	436	1025	1252	777	1245	1494
Adjustments	-2	-0	-0	-0	-0	-0	-0	0	0	0	0	0
Profit After Adjustments	433	664	751	1733	934	678	436	1025	1252	777	1245	1494
Adjusted Earnings Per Share	12.8	19.6	22.2	51.2	27.6	20	12.9	30.3	37	23	36.8	44.2

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	13%	7%	10%	12%
Operating Profit CAGR	10%	8%	12%	15%
PAT CAGR	60%	7%	13%	11%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	56%	24%	26%	23%
ROE Average	21%	19%	18%	27%
ROCE Average	20%	17%	15%	23%

Torrent Pharma Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	1422	1902	2491	3494	4350	4622	4724	4823	5837	5953	6198
Minority's Interest	0	0	0	0	0	1	0	0	0	0	0
Borrowings	455	744	2185	1850	2241	4111	3913	3304	2941	2123	2496
Other Non-Current Liabilities	165	182	320	145	62	31	-52	-5	-17	115	327
Total Current Liabilities	1711	2175	2824	3285	2738	5202	5165	5454	4892	4415	5447
Total Liabilities	3753	5004	7820	8775	9392	13967	13751	13577	13653	12606	14468
Fixed Assets	820	875	2833	2859	3688	7855	7748	7533	7065	6423	8121
Other Non-Current Assets	372	724	936	1227	824	850	966	1062	1065	889	1018
Total Current Assets	2561	3404	4051	4688	4879	5262	5038	4979	5522	5165	5314
Total Assets	3753	5004	7820	8775	9392	13967	13751	13577	13653	12606	14468

Torrent Pharma Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	761	687	955	612	1050	1068	702	589	662	573	398
Cash Flow from Operating Activities	153	599	810	2742	1009	894	1798	1393	2005	1803	2368
Cash Flow from Investing Activities	-242	-356	-2162	-838	-787	-4707	-241	199	-449	-197	-2415
Cash Flow from Financing Activities	20	86	1212	-1435	-193	3417	-1314	-1549	-1651	-1781	77
Net Cash Inflow / Outflow	-68	330	-140	469	29	-395	242	42	-95	-175	30
Closing Cash & Cash Equivalent	687	955	865	1050	1068	702	940	662	573	398	509

Torrent Pharma Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	12.79	19.61	22.19	51.21	27.58	20.03	12.89	30.27	36.99	22.96	36.79
CEPS(Rs)	15.29	22.18	27.82	58.23	36.65	32.11	31.14	49.61	56.42	42.52	57.67
DPS(Rs)	23	10	11.25	17.5	14	14	17	32	35	48	22
Book NAV/Share(Rs)	42.01	56.21	73.58	103.23	128.52	136.56	139.58	142.5	172.45	175.87	183.13
Core EBITDA Margin(%)	21.51	22.7	21.89	40.82	23.52	11.91	13.61	14.51	16.67	15.98	17.27
EBIT Margin(%)	19.12	21.53	23.92	37.8	22.09	11.01	7.33	10.95	12.63	9.74	13.34
Pre Tax Margin(%)	18.07	20.13	20.16	35.05	18.58	8.27	3.87	7.94	10.26	8.06	11.3
PAT Margin (%)	13.51	15.84	16.11	25.92	15.94	6.02	3	6.85	8.41	5.11	7.61
Cash Profit Margin (%)	16.08	17.91	20.2	29.47	21.18	9.65	7.26	11.23	12.84	9.46	11.94
ROA(%)	12.79	15.16	11.71	20.89	10.28	5.81	3.15	7.5	9.2	5.92	9.2
ROE(%)	33.25	39.94	34.19	57.92	23.8	15.12	9.34	21.47	23.49	13.18	20.5
ROCE(%)	31.66	35.06	26.98	45.63	20.36	13.81	9.75	15.28	17.62	14.35	20.32
Receivable days	68.65	77.81	105.19	82.76	74.66	35.74	33.78	37.65	38.92	37.86	39.91
Inventory Days	82.53	84.02	81.17	66.19	90.9	57.16	49.01	49.84	59.24	61.71	52.36
Payable days	436.21	411.42	464.01	520.94	449.01	451.45	370.58	381.76	383.19	306.08	243.5
PER(x)	13.59	13.35	26.16	13.08	28.09	31.14	75.73	32.56	34.35	60.89	41.79
Price/Book(x)	4.14	4.66	7.89	6.49	6.03	4.57	6.99	6.92	7.37	7.95	8.4
Dividend Yield(%)	3.31	1.91	0.97	2.61	0.9	1.12	0.87	1.62	1.38	1.72	1.43
EV/Net Sales(x)	1.85	2.2	4.69	3.66	4.79	4.49	4.99	4.85	5.9	5.99	5.9
EV/Core EBITDA(x)	8.09	9.32	16.71	8.24	17.39	16.21	18.75	16.82	18.62	19.38	19.66
Net Sales Growth(%)	19.11	30.32	11.2	43.27	-12.77	2.31	28.96	3.47	0.82	6.29	13.07
EBIT Growth(%)	54.6	46.67	23.53	126.68	-48.82	-4.19	-14.04	53.68	14.78	-21.19	47.24
PAT Growth(%)	51.91	52.65	13.11	130.8	-46.14	-27.36	-35.66	134.86	22.17	-37.92	60.22
EPS Growth(%)	52.36	53.41	13.11	130.81	-46.14	-27.36	-35.66	134.88	22.17	-37.92	60.23
Debt/Equity(x)	0.49	0.59	1.1	0.67	0.58	1.4	1.28	1.21	0.83	0.68	0.85
Current Ratio(x)	1.5	1.57	1.43	1.43	1.78	1.01	0.98	0.91	1.13	1.17	0.98
Quick Ratio(x)	0.97	1.11	1.06	1.02	1.22	0.64	0.6	0.52	0.59	0.62	0.57
Interest Cover(x)	18.21	15.4	6.37	13.74	6.29	4.02	2.11	3.63	5.32	5.81	6.54
Total Debt/Mcap(x)	0.12	0.13	0.14	0.1	0.1	0.31	0.18	0.18	0.11	0.08	0.1

Torrent Pharma Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25
FII	11.63	10.88	10.8	11.37	12.09	12.04	12.84	13.15	14.09	14.14
DII	8.94	9.73	10.01	9.51	8.87	9	8.31	8	7.21	7.26
Public	8.18	8.14	7.95	7.88	7.8	7.71	7.6	7.6	7.45	7.36
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	12.06	12.06	12.06	24.11	24.11	24.11	24.11	24.11	24.11	24.11
FII	1.97	1.84	1.83	3.85	4.09	4.08	4.35	4.45	4.77	4.78
DII	1.51	1.65	1.69	3.22	3	3.05	2.81	2.71	2.44	2.46
Public	1.38	1.38	1.35	2.67	2.64	2.61	2.57	2.57	2.52	2.49
Others	0	0	0	0	0	0	0	0	0	0
Total	16.92	16.92	16.92	33.84	33.84	33.84	33.84	33.84	33.84	33.84

Pros

Debtor days have improved from 306.08 to 243.5days.

Cons

Stock is trading at 12.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Torrent Pharma News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Torrent Pharma

Add Watchlist

Torrent Pharma Research see more...

Overview Inc. Year: 1972Industry: Pharmaceuticals & Drugs

Torrent Pharma Share Price

Alert Data

Quarterly Price

Peer Comparison

Torrent Pharma Quarterly Results

Torrent Pharma Profit & Loss

Growth Rates

Torrent Pharma Balance Sheet

Torrent Pharma Cash Flow

Torrent Pharma Ratios

Torrent Pharma Shareholding Pattern

Torrent Pharma News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!